{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T02:43:07Z","timestamp":1787625787241,"version":"build-2736575974"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T00:00:00Z","timestamp":1643932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2020M683094"],"award-info":[{"award-number":["2020M683094"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972263"],"award-info":[{"award-number":["81972263"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072714"],"award-info":[{"award-number":["82072714"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103221"],"award-info":[{"award-number":["82103221"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec><jats:title>Background and Aims<\/jats:title><jats:p>Despite the remarkable progress of metabolic dysfunction-associated fatty liver disease (MAFLD), formerly named non-alcoholic fatty liver disease (NAFLD), the disease remains poorly improved. Since increased oxidative stress and inflammation contribute to the initiation and progression of fatty liver disorders, vitamin C (VC), an antioxidant agent, might be a suitable treatment option for MAFLD. However, the lack of clinically confirmed benefits makes clinicians challenging to recommend antioxidant supplements for MAFLD individuals.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Herein, the nationally representative National Health and Nutrition Examination Survey 2017\u20132018 data were collected to evaluate the potential association between the serum VC levels with the risk of different categories of NALFD and the newly proposed MAFLD terminology. Hepatic steatosis was defined as controlled attenuated parameter scores \u2265 263 dB\/m, whereas liver fibrosis (LF) status was defined as F0\u2013F4, with the cutoff values of median liver stiffness being 6.3, 8.3, 10.5, and 12.5 (KPa), respectively. A cross-sectional analysis was performed to calculate the odds rate and determine the potential beneficial effects of VC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 4,494 participants aged more than 18 years and conducted transient elastography examinations were included. Our findings demonstrated that participants with increased serum VC status were more likely to be female predominant, more educated, and moderate drinkers. Interestingly, female participants tended to have a lower prevalence of NAFLD, MAFLD, LF, and liver cirrhosis (LC) after stratification by gender. Moreover, our results revealed that participants from the quartile three group (quartile 3: 50.5\u201367.0 \u03bcmol\/L) experienced a slightly lower risk of MAFLD than the risk of NAFLD. Of note, the serum concentration of VC (quartile 2: 30.9\u201350.5 \u03bcmol\/L) inversely associated with LF and LC was lower than the serum VC level (quartile 3) associated with NAFLD and MAFLD. Notably, individuals from the quartile 3 group experienced a statistically significant 32.5, 42.0, 45.7, and 71% decrease in risk of NAFLD, MAFLD, LF, and LC, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In summary, our findings suggested an inverse association between serum VC levels and NAFLD, MAFLD, LF, or LC. Additionally, adjustment of VC supplementation according to age, gender, and ethnicity may be a promising candidate for these diseases.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnut.2021.795391","type":"journal-article","created":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T06:55:16Z","timestamp":1643957716000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":36,"title":["Association of Serum Vitamin C With NAFLD and MAFLD Among Adults in the United States"],"prefix":"10.3389","volume":"8","author":[{"given":"Zhi-Qin","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Liang","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Wu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Zhen","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Jin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1002\/hep.28123","article-title":"Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009","volume":"62","author":"Younossi","year":"2015","journal-title":"Hepatology (Baltimore, Md)."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.07.035","article-title":"Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States","author":"Kim","year":"2021","journal-title":"J Hepatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1111\/liv.14828","article-title":"Prevalence of NAFLD, MAFLD and associated advanced fibrosis in the contemporary United States population","volume":"41","author":"Ciardullo","year":"2021","journal-title":"Liver Int."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1002\/hep.23594","article-title":"Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection","volume":"51","author":"Starley","year":"2010","journal-title":"Hepatology."},{"key":"B6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/cld.722","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"11","author":"Chalasani N","year":"2018","journal-title":"Clin Liver Dis (Hoboken)."},{"key":"B7","doi-asserted-by":"publisher","first-page":"76","DOI":"10.14218\/JCTH.2019.00051","article-title":"Non-alcoholic fatty liver disease: growing burden, adverse outcomes and associations","volume":"8","author":"Kumar","year":"2020","journal-title":"J Clin Transl Hepatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"113869","DOI":"10.1016\/j.addr.2021.113869","article-title":"Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis","volume":"176","author":"Kumar","year":"2021","journal-title":"Adv Drug Deliv Rev."},{"key":"B9","doi-asserted-by":"publisher","first-page":"E484","DOI":"10.1152\/ajpendo.00492.2015","article-title":"Lipotoxicity in steatohepatitis occurs despite an increase in tricarboxylic acid cycle activity","volume":"310","author":"Patterson","year":"2016","journal-title":"Am J Physiol Endocrinol Metab."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1194\/jlr.M023382","article-title":"Elevated TCA cycle function in the pathology of diet-induced hepatic insulin resistance and fatty liver","volume":"53","author":"Satapati","year":"2012","journal-title":"J Lipid Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"S186","DOI":"10.1046\/j.1440-1746.17.s1.10.x","article-title":"Non-alcoholic fatty liver disease","volume":"17","author":"Angulo","year":"2002","journal-title":"J Gastroenterol Hepatol."},{"key":"B12","first-page":"1","article-title":"National Health and Nutrition Examination Survey, 2015-2018: sample design and estimation procedures","volume":"2","author":"Chen","year":"2020","journal-title":"Vital Health Stat"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e296","DOI":"10.1371\/journal.pmed.0040296","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"4","author":"von Elm","year":"2007","journal-title":"PLoS Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"100037","DOI":"10.1016\/j.ijchy.2020.100037","article-title":"Low serum vitamin C correlates with an increased risk of peripheral arterial disease in current smokers: results from NHANES 2003-2004","volume":"6","author":"Cong","year":"2020","journal-title":"Int J Cardiol Hypertens."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1097\/j.pain.0000000000000671","article-title":"Serum vitamin C and spinal pain: a nationwide study","volume":"157","author":"Dionne","year":"2016","journal-title":"Pain."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1002\/hep.29302","article-title":"Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: a meta-analysis","volume":"66","author":"Xiao","year":"2017","journal-title":"Hepatology."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e021787","DOI":"10.1136\/bmjopen-2018-021787","article-title":"Diagnostic accuracy of point shear wave elastography and transient elastography for staging hepatic fibrosis in patients with non-alcoholic fatty liver disease: a meta-analysis","volume":"8","author":"Jiang","year":"2018","journal-title":"BMJ Open."},{"key":"B18","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.cgh.2018.04.043","article-title":"Vibration-controlled transient elastography to assess fibrosis and steatosis in patients with nonalcoholic fatty liver disease","volume":"17","author":"Siddiqui","year":"2019","journal-title":"Clin Gastroenterol Hepatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1002\/hep.28394","article-title":"Liver stiffness in nonalcoholic fatty liver disease: a comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy","volume":"63","author":"Cassinotto","year":"2016","journal-title":"Hepatology."},{"key":"B20","first-page":"362","article-title":"Testing for HCV infection: an update of guidance for clinicians and laboratorians","volume":"62","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1053\/j.gastro.2018.11.037","article-title":"New and old biomarkers for diagnosis and management of chronic hepatitis B virus infection","volume":"156","author":"Coffin","year":"2019","journal-title":"Gastroenterology."},{"key":"B22","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.2337\/dc20-S002","article-title":"2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2020","volume":"43","year":"2020","journal-title":"Diabetes Care."},{"key":"B23","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2147\/NSS.S290465","article-title":"Circadian misalignment rather than sleep duration is associated with mafld: a population-based propensity score-matched study","volume":"13","author":"Weng","year":"2021","journal-title":"Nat Sci Sleep."},{"key":"B25","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.aohep.2020.03.006","article-title":"Blood lead level is associated with advanced liver fibrosis in patients with non-alcoholic fatty liver disease: a nationwide survey (NHANES 2011-2016)","volume":"19","author":"Reja","year":"2020","journal-title":"Ann Hepatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1001\/jama.2018.14854","article-title":"The physical activity guidelines for Americans","volume":"320","author":"Piercy","year":"2018","journal-title":"JAMA."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s00125-016-3902-y","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"59","year":"2016","journal-title":"Diabetologia."},{"key":"B28","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1136\/gutjnl-2019-318813","article-title":"Epidemiology of chronic liver diseases in the USA in the past three decades","volume":"69","author":"Younossi","year":"2020","journal-title":"Gut."},{"key":"B29","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J Hepatol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1017\/S0007114509993229","article-title":"Is vitamin C supplementation beneficial? Lessons learned from randomised controlled trials","volume":"103","author":"Lykkesfeldt","year":"2010","journal-title":"Br J Nutr."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.3390\/nu12051501","article-title":"Two faces of vitamin c-antioxidative and pro-oxidative agent","volume":"12","author":"Kazmierczak-Baranska","year":"2020","journal-title":"Nutrients."},{"key":"B32","doi-asserted-by":"publisher","first-page":"101290","DOI":"10.1016\/j.redox.2019.101290","article-title":"Redox modifications of cysteine-containing proteins, cell cycle arrest and translation inhibition: involvement in vitamin C-induced breast cancer cell death","volume":"26","author":"El Banna","year":"2019","journal-title":"Redox Biol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.etp.2010.09.011","article-title":"High-dose vitamin C: does it exacerbate the effect of psychosocial stress on liver? biochemical and histological study","volume":"64","author":"Abdul-Razzak","year":"2012","journal-title":"Exp Toxicol Pathol."},{"key":"B34","first-page":"8","article-title":"Mega-dose Vitamin C: is it harmful to the liver? biochemical and histological study in rats","volume":"5","author":"Abdul-Razzak","year":"2012","journal-title":"Jordan J Pharm Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"110792","DOI":"10.1016\/j.biopha.2020.110792","article-title":"Prophylactic and therapeutic effects of different doses of vitamin C on high-fat-diet-induced non-alcoholic fatty liver disease in mice","volume":"131","author":"Zeng","year":"2020","journal-title":"Biomed Pharmacother."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e0147985","DOI":"10.1371\/journal.pone.0147985","article-title":"Association between dietary vitamin C intake and non-alcoholic fatty liver disease: a cross-sectional study among middle-aged and older adults","volume":"11","author":"Wei","year":"2016","journal-title":"PLoS ONE."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1016\/j.dld.2019.06.005","article-title":"Dietary vitamin E and C intake is inversely associated with the severity of nonalcoholic fatty liver disease","volume":"51","author":"Ivancovsky-Wajcman","year":"2019","journal-title":"Dig Liver Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"749","DOI":"10.5713\/ajas.2013.13852","article-title":"Effects of Vitamin C or E on the Pro-inflammatory Cytokines, Heat Shock Protein 70 and Antioxidant Status in Broiler Chicks under Summer Conditions","volume":"27","author":"Jang","year":"2014","journal-title":"Asian Australas J Anim Sci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.2174\/138161282006140220144802","article-title":"Consumption of mixed fruit-juice drink and vitamin C reduces postprandial stress induced by a high fat meal in healthy overweight subjects","volume":"20","author":"Peluso","year":"2014","journal-title":"Curr Pharm Des."},{"key":"B40","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.2147\/DDDT.S83144","article-title":"Khaza'ai H, Abed Y. Effect of vitamin C on inflammation and metabolic markers in hypertensive and\/or diabetic obese adults: a randomized controlled trial","volume":"9","author":"Ellulu","year":"2015","journal-title":"Drug Des Devel Ther."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.ajpath.2021.05.020","article-title":"Vitamin C deficiency inhibits nonalcoholic fatty liver disease progression through impaired de novo lipogenesis","volume":"191","author":"Lee","year":"2021","journal-title":"Am J Pathol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1097\/HJH.0000000000002835","article-title":"Blood pressure, glycemic status and advanced liver fibrosis assessed by transient elastography in the general United States population","volume":"39","author":"Ciardullo","year":"2021","journal-title":"J Hypertens."},{"key":"B43","doi-asserted-by":"publisher","first-page":"5193","DOI":"10.2174\/1381612811319290004","article-title":"Non invasive indexes for the assessment of patients with non-alcoholic fatty liver disease","volume":"19","author":"Petta","year":"2013","journal-title":"Curr Pharm Des."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.7150\/thno.18650","article-title":"Ultrasound elastography: review of techniques and clinical applications","volume":"7","author":"Sigrist","year":"2017","journal-title":"Theranostics."}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2021.795391\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T06:55:29Z","timestamp":1643957729000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2021.795391\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,4]]},"references-count":44,"alternative-id":["10.3389\/fnut.2021.795391"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2021.795391","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,4]]},"article-number":"795391"}}